Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Global Blood Therapeutics
Global Blood Therapeutics
(GBT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Oxbryta
Voxelotor
2019-11-25
2032-2037
Anemia
,
Sickle cell anemia
,
Hemolytic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voxelotor
renal insufficiency
,
healthy volunteers/patients
,
hypoxia
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
chronic renal insufficiency
,
kidney diseases
,
sickle cell anemia
,
anemia
Menatetrenone
thromboembolism
,
venous thromboembolism
,
pulmonary embolism
Retinol
colorectal neoplasms
,
non-hodgkin lymphoma
,
hodgkin disease
,
healthy volunteers/patients
,
melanoma
,
type 2 diabetes mellitus
,
pancreatic neoplasms
,
renal cell carcinoma
,
kidney neoplasms
,
leukemia
,
hematologic neoplasms
,
lymphoma
,
sezary syndrome
,
b-cell chronic lymphocytic leukemia
,
prolymphocytic leukemia t-cell
,
t-cell lymphoma
,
prolymphocytic leukemia
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
prolymphocytic leukemia b-cell
,
adenocarcinoma
,
non-small-cell lung carcinoma
,
osteoporosis
,
postmenopausal osteoporosis
,
hiv
Carbendazim
neoplasms
,
constipation
,
sickle cell anemia
,
healthy volunteers/patients
,
spine osteoarthritis
,
lymphoma
,
coronary artery bypass
,
glioblastoma
,
psoriasis
,
colonic neoplasms
,
myelodysplastic syndromes
,
disease progression
,
preleukemia
,
syndrome
,
delirium
,
sleep
,
malaria
,
dna damage
,
anxiety
,
phobic disorders
,
respiratory tract infections
,
infections
,
communicable diseases
,
multiple myeloma
,
plasma cell neoplasms
,
neoadjuvant therapy
,
rectal neoplasms
,
heart failure
,
aortic valve disease
,
mitral valve insufficiency
,
cardiac surgical procedures
,
cardiovascular diseases
,
myocardial infarction
,
insulin resistance
,
covid-19
,
hyperglycemia
,
epilepsy
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
,
pneumococcal infections
,
streptococcal infections
,
ovarian neoplasms
,
tick-borne encephalitis
,
encephalitis
,
lyme disease
,
borrelia infections
,
bone fractures
,
infertility
,
central serous chorioretinopathy
,
unstable angina
,
cardiac arrhythmias
,
water-electrolyte balance
,
type 2 diabetes mellitus
,
body weight
,
birth weight
,
anxiety disorders
,
low back pain
,
back pain
,
myopia
,
hydrophilic contact lenses
,
stomach neoplasms
,
peripheral nervous system diseases
,
prenatal care
,
perinatal care
,
mental health services
,
inflammation
,
tooth discoloration
,
osteoporosis
,
femoral neck fractures
,
aneuploidy
,
retinopathy of prematurity
,
analgesia
,
postoperative pain
,
papilloma
,
pregnancy rate
,
puerperal disorders
,
gingival recession
,
attention deficit disorder with hyperactivity
,
vaginitis
,
contracture
,
cerebral palsy
,
paralysis
,
hip fractures
,
wounds and injuries
,
macular edema
,
macular degeneration
,
edema
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use